GSA Capital Partners’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-36,923
| Closed | -$85K | – | 1443 |
|
|
2023
Q2 | $85K | Sell |
36,923
-1,237
| -3% | -$2.85K | 0.01% | 1391 |
|
|
2023
Q1 | $116K | Sell |
38,160
-79,031
| -67% | -$240K | 0.01% | 1337 |
|
|
2022
Q4 | $273K | Buy |
117,191
+22,391
| +24% | +$52.2K | 0.03% | 999 |
|
|
2022
Q3 | $181K | Buy |
94,800
+78,664
| +488% | +$150K | 0.02% | 1258 |
|
|
2022
Q2 | $44K | Sell |
16,136
-16,317
| -50% | -$44.5K | 0.01% | 1297 |
|
|
2022
Q1 | $97K | Buy |
+32,453
| New | +$97K | 0.01% | 1298 |
|
|
2021
Q2 | – | Sell |
-309,839
| Closed | -$1.03M | – | 1285 |
|
|
2021
Q1 | $1.03M | Buy |
309,839
+283,618
| +1,082% | +$945K | 0.17% | 125 |
|
|
2020
Q4 | $93K | Buy |
+26,221
| New | +$93K | 0.02% | 1103 |
|